Multicentre study of the in vitro evaluation of moxifloxacin and other quinolones against community acquired respiratory pathogens

The in vitro activity of moxifloxacin was compared with that of ciprofoxacin, levofloxacin, ofloxacin and trovafloxacin against 710 strains (180 Streptococcus pneumoniae, 180 Haemophilus influenzae, 160 Moraxella catarrhalis and 190 Streptococcus pyogenes) isolated from patients with community-acquired respiratory tract infections. MIC values for moxifloxacin, trovafloxacin were 0.25/0.25 0.03/0.03. 0.06, 0.03 and 0.125/0.0125 mg/l for S. pneumoniae, H. influenzae, M. catharralis and S. pyogenes. Based upon the MIC90 values and the MIC distributions. moxifloxacin and trovafloxacin were the most active of the quinolones tested. They showed enhanced activity against Gram-positive organisms including penicillin non susceptible S. pneumoniae strains. Moxifloxacin was also highly active against ciprofloxacin-resistant S. pneumoniae strains. (C) 2001 Published by Elsevier Science B.V. on behalf of the International Society of Chemotherapy.